Somnomed improves Q3 sales 28%
10/04/2014 11:46:00
This video is not supported on your device. Click here for the original version.
The result was aided by sales records in US markets and the growth adds to gains made in the first half of the year.
Investors responded well to the announcement with the company’s share price jumping more than 15 per cent in morning trade.
Somnomed made a net profit of $8,000 in the first half of the 2014 financial year.